Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy.
作者信息
Li Yingxin, Sallam Karim, Schwartz Peter J, Wu Joseph C
机构信息
From the Stanford Cardiovascular Institute, Departments of Medicine and Radiology, Institute of Stem Cell Biology & Regenerative Medicine (Y.L., K.S., J.C.W.), Stanford University, School of Medicine, CA; and Center for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milano, Italy (P.J.S.).
出版信息
Circ Arrhythm Electrophysiol. 2017 Jun;10(6). doi: 10.1161/CIRCEP.117.005398.
Abstract
摘要
相似文献
1
Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy.用于发病机制研究和临床药物治疗的患者特异性诱导多能干细胞疾病模型
Circ Arrhythm Electrophysiol. 2017 Jun;10(6). doi: 10.1161/CIRCEP.117.005398.
2
The unstoppable attraction for induced pluripotent stem cells: are they the magic bullet for modeling inherited arrhythmogenic diseases?
J Am Coll Cardiol. 2012 Sep 11;60(11):1001-4. doi: 10.1016/j.jacc.2012.04.019. Epub 2012 Jun 27.
3
Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.使用2型儿茶酚胺能多形性室性心动过速的人诱导多能干细胞模型进行患者特异性药物筛选
Circ Arrhythm Electrophysiol. 2017 Jun;10(6). doi: 10.1161/CIRCEP.116.004725.
4
Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.与严重儿茶酚胺能多形性室性心动过速相关的新型钙调蛋白变体p.E46K在人诱导多能干细胞衍生的心肌细胞中产生强大的致心律失常性。
Circ Arrhythm Electrophysiol. 2023 Mar;16(3):e011387. doi: 10.1161/CIRCEP.122.011387. Epub 2023 Mar 3.
5
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.应用患者特异性人诱导多能干细胞对儿茶酚胺多形性室性心动过速进行建模。
J Am Coll Cardiol. 2012 Sep 11;60(11):990-1000. doi: 10.1016/j.jacc.2012.02.066. Epub 2012 Jun 27.
6
Generation of catecholaminergic polymorphic ventricular tachycardia patient-specific induced pluripotent stem cell line.儿茶酚胺能多形性室性心动过速患者特异性诱导多能干细胞系的生成。
Stem Cell Res. 2022 Apr;60:102727. doi: 10.1016/j.scr.2022.102727. Epub 2022 Feb 25.
7
In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.利用人类诱导多能干细胞对兰尼碱受体2功能障碍进行体外建模。
Cell Physiol Biochem. 2011;28(4):579-92. doi: 10.1159/000335753. Epub 2011 Dec 14.
8
Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations.从携带 RYR2 突变的儿茶酚胺多形性室性心动过速患者中生成两个诱导多能干细胞系。
Stem Cell Res. 2023 Jun;69:103111. doi: 10.1016/j.scr.2023.103111. Epub 2023 May 12.
9
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.丹曲林钠挽救儿茶酚胺多形性室性心动过速患者特异性干细胞模型中的致心律失常 RYR2 缺陷。
EMBO Mol Med. 2012 Mar;4(3):180-91. doi: 10.1002/emmm.201100194. Epub 2012 Jan 25.
10
Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.通过电起搏评估的患者特异性人诱导多能干细胞模型验证了S107作为儿茶酚胺能多形性室性心动过速潜在治疗药物的有效性。
PLoS One. 2016 Oct 20;11(10):e0164795. doi: 10.1371/journal.pone.0164795. eCollection 2016.
引用本文的文献
1
Generation of two iPSC lines from dilated cardiomyopathy patients with pathogenic variants in the SCN5A gene.从 SCN5A 基因突变的扩张型心肌病患者中生成两个 iPSC 系。
Stem Cell Res. 2024 Oct;80:103498. doi: 10.1016/j.scr.2024.103498. Epub 2024 Jul 20.
2
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
3
Macrophages Modulate the Function of MSC- and iPSC-Derived Fibroblasts in the Presence of Polyethylene Particles.巨噬细胞在聚乙烯颗粒存在的情况下调节 MSC 和 iPSC 衍生的成纤维细胞的功能。
Int J Mol Sci. 2021 Nov 27;22(23):12837. doi: 10.3390/ijms222312837.
4
Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.同源诱导多能干细胞的生成和评估：用于 Kearns-Sayre 综合征患者的细胞替代治疗。
Cells. 2021 Mar 5;10(3):568. doi: 10.3390/cells10030568.
5
Atrial Fibrillation in Inherited Channelopathies.遗传性通道病中的心房颤动。
Card Electrophysiol Clin. 2021 Mar;13(1):155-163. doi: 10.1016/j.ccep.2020.10.004. Epub 2021 Jan 8.
6
7
Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.迈向精准医疗：人类诱导多能干细胞在心脏通道病中的应用
Circ Res. 2019 Aug 30;125(6):653-658. doi: 10.1161/CIRCRESAHA.119.315209. Epub 2019 Aug 29.
8
Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics.诱导多能干细胞用于研究核纤层蛋白病的机制：聚焦于表观遗传学
Front Cell Dev Biol. 2018 Dec 20;6:172. doi: 10.3389/fcell.2018.00172. eCollection 2018.
9
A human population-based organotypic in vitro model for cardiotoxicity screening.用于心脏毒性筛选的基于人体的器官型体外模型。
ALTEX. 2018;35(4):441-452. doi: 10.14573/altex.1805301. Epub 2018 Jul 8.
本文引用的文献
1
Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.使用2型儿茶酚胺能多形性室性心动过速的人诱导多能干细胞模型进行患者特异性药物筛选
Circ Arrhythm Electrophysiol. 2017 Jun;10(6). doi: 10.1161/CIRCEP.116.004725.
2
Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.患者特异性和基因编辑诱导多能干细胞衍生的心肌细胞阐明了布加综合征的单细胞表型。
J Am Coll Cardiol. 2016 Nov 8;68(19):2086-2096. doi: 10.1016/j.jacc.2016.07.779.
3
Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.人类诱导多能干细胞作为个性化精准心血管医学的一个平台
Physiol Rev. 2016 Jul;96(3):1093-126. doi: 10.1152/physrev.00036.2015.
4
Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.人类诱导多能干细胞的翻译：从培养皿中的临床试验到精准医学
J Am Coll Cardiol. 2016 May 10;67(18):2161-2176. doi: 10.1016/j.jacc.2016.01.083.
5
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.诱导多能干细胞：心血管精准医学的核心。
Nat Rev Cardiol. 2016 Jun;13(6):333-49. doi: 10.1038/nrcardio.2016.36. Epub 2016 Mar 24.
6
Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes.人诱导多能干细胞衍生的心肌细胞：对分子、细胞和功能表型的见解。
Circ Res. 2015 Jun 19;117(1):80-8. doi: 10.1161/CIRCRESAHA.117.305365.
7
Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.探寻心脏性猝死的节律：利用诱导多能干细胞衍生的心肌细胞带来的新机遇
Circ Res. 2015 Jun 5;116(12):1989-2004. doi: 10.1161/CIRCRESAHA.116.304494.
8
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.儿茶酚胺多形性室性心动过速的临床处理：左侧心脏交感神经切除术的作用。
Circulation. 2015 Jun 23;131(25):2185-93. doi: 10.1161/CIRCULATIONAHA.115.015731. Epub 2015 May 27.
9
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
10
Stem cells: disease models that show and tell.干细胞：展示和讲述疾病模型的工具。
Nat Methods. 2015 Jan 29;12(2):111-4. doi: 10.1038/nmeth.3263.
Zotero 插件